Namodenoson Treatment of Advanced Pancreatic Cancer
NCT06387342
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatic Adenocarcinoma
Pancreatic Cancer
Interventions
DRUG:
Namodenoson 25mg
Sponsor
Can-Fite BioPharma